1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281 (6): 537–44.
2. Laumann EO, Nicolosi A, Glasser DB et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17 (1): 39–57.
3. Аляев Ю.Г., Ахвледиани Н.Д. Первые результаты российского интерактивного опроса по преждевременному семяизвержению. Врач. 2008; 6: 28–9.
4. McMahon CG, Althof SE, Waldinger MD et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008; 5 (7): 1590–606.
5. Patrick D, Althof S, Pryor J et al. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005; 2: 358–67.
6. Аляев Ю.Г., Ахвледиани Н.Д. Преждевременная эякуляция – Terra Incognita в андрологии. Врач. 2007; 7: 13–6.
7. Wespes E, Amar E, Eardley I et al. Vardi.Guidelines on Male Sexual Dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology, 2009; p. 1–47.
8. Salonia A, Maga T, Colombo R et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002; 168: 2486–9.
9. Hosseini MM, Yarmohammadi H. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. Urol Int 2007; 79 (1): 28–32.
10. Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008; 80 (2): 162–5.
11. Закон Российской Федерации «Основы законодательства Российской Федерации об охране здоровья граждан». М.: Ось-89, 2009.
12. Tandt H, Audenaert K, van Heeringen C. SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children Tijdschr Psychiatr 2009; 51 (6): 387–93.
13. Pfaus JG. Neurobiology of sexual behavior. Curr Opin Neurobiol 1999; 9: 751–8.
14. Sato Y, Christ GJ, Horita H et al. The effects of alterations in nitric oxide levels in the paraventricular nucleus on copulatory behavior and reflexive erections in male rats. J Urol 1999; 162: 2182–5.
15. Sato Y, Zhao W, Christ GJ. Central modulation of the NO/cGMP pathway affects the MPOA-induced intracavernous pressure response. Am J Physiol Regul Integr Comp Physiol 2001; 281: R269–78.
16. Prickaerts J, van Staveren WC, Sik A et al. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognitionmemory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002; 113: 351–61.
17. Jain NK, Patil CS, Singh A, Kulkarni SK. Sildenafil-induced peripheral analgesia and activation of the nitric oxidecyclic GMP pathway. Brain Res 2001; 909: 170–8.
18. Vanden Broucke H, Everaert K, Peersman W et al. Ejaculation latency times and their relationship to penile sensitivity in men with normal sexual function. J Urol 2007; 177: 237–40.
19. Porst H, Padma-Nathan H, Giuliano F et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 2003; 62 (1): 121–5.
Авторы
Ю.Г.Аляев, А.З.Винаров, Н.Д.Ахвледиани
Кафедра урологии ГОУ ВПО Первый МГМУ им. И.М.Сеченова Минздравсоцразвития РФ